反応式
Cl[C:2]1[N:7]=[N:6][C:5]([C:8]([OH:11])([CH3:10])[CH3:9])=[CH:4][CH:3]=1.[NH2:12][C:13]1[S:14][C:15]([C:21]2[CH:26]=[CH:25][C:24]([C:27]([OH:30])([CH3:29])[CH3:28])=[CH:23][C:22]=2[F:31])=[CH:16][C:17]=1[C:18]([NH2:20])=[O:19]>>[F:31][C:22]1[CH:23]=[C:24]([C:27]([OH:30])([CH3:28])[CH3:29])[CH:25]=[CH:26][C:21]=1[C:15]1[S:14][C:13]([NH:12][C:2]2[N:7]=[N:6][C:5]([C:8]([OH:11])([CH3:10])[CH3:9])=[CH:4][CH:3]=2)=[C:17]([C:18]([NH2:20])=[O:19])[CH:16]=1参加物
3
実験手順
The title compound was prepared by using the procedure listed in Example 1 with starting materials 2-(6-chloropyridazin-3-yl)propan-2-ol (Intermediate 45) (117 mg, 0.68 mmol) and 2-amino-5-[2-fluoro-4-(1-hydroxy-1-methylethyl)phenyl]thiophene-3-carboxamide (200 mg, 0.68 mmol).
出典と根拠
- ORDレコード
- ord-9c87e8e43b5343138ba63c401fc048ec
- 出典データセット
- uspto-grants-2013_02
- 特許番号
- US08367706B2
関連ノート
読み込み中…